Making the most of what you have

October 8, 2013
Like the Matryoshka doll, the NS3 protein can generate smaller fractions of itself. Credit: Frauke Lejeune / Vetmeduni Vienna

Understanding how viral proteins are produced can provide important clues on how we might interfere with the process. The group of Till Rümenapf at the University of Veterinary Medicine Vienna has discovered that a key protease of a particular virus breaks itself down into two different functional molecules. The findings are reported in the Journal of Virology and may have important implications for the development of defense strategies against diseases caused by flaviviruses.

We generally do not devote much time to worrying about the problems faced by viruses, although understanding them may provide clues on how to combat diseases. Viruses rely on the machinery of the host cell but must supply specific functions via their own proteins and RNA molecules. All of these need to be coded in as little genetic material as possible, so it is often the case that a single viral protein is able, indeed required, to undertake a number of different tasks. And the requirement to minimize the amount of DNA or RNA often leads viruses to lump all their proteins in a single gene, encoding what is known as a polyprotein. Polyproteins are a typical feature of RNA viruses, such as .

Flaviviruses in animals and man

Flaviviruses are responsible for a wide range of diseases in humans (such as tick borne encephalitis, dengue fever and hepatitis C) and animals (such as bovine viral diarrhoea and classical swine fever). Understanding how they function represents a key first step in the development of effective countermeasures or cures, so work on flaviviruses forms an import focus of a large number of research institutions worldwide.

The University of Veterinary Medicine Vienna has been contributing to the field since the appointment in 2012 of Till Rümenapf.

Rümenapf works on classical swine fever , CSFV, an RNA virus that encodes a single protein that must be broken down into twelve building blocks before the virus can exert any of its unwelcome effects on pigs. Key among the "mature proteins" are those responsible for chopping off the various pieces to produce . The so-called "nonstructural protein 3" (NS3) appears to have a crucial role: not only is its activity important in the production of a number of other , it also harbours further functions that are essential for replicating the viral RNA and for the formation of the virus particle.

Benjamin Lamp and colleagues in Rümenapf's group have investigated NS3 in more detail. Surprisingly, they found that NS3 also attacks itself, generating two smaller proteins. The fractions are not merely breakdown products – proteases can naturally digest themselves – but proteins with distinct activities, a protease and a helicase (which is involved in RNA replication). The protease can actually cleave itself a further time, cutting off a small portion and leaving the remainder inactive.

Self-cleavage of NS3 is essential

The NS3 protease cuts proteins, even itself, only at precisely defined positions. Lamp altered the two newly detected cleavage sites and examined the effect on the virus. Changes at either site were found to cause dramatic drops in the efficiency of viral replication, strongly suggesting that both cleavages are important for the viral life-cycle, although what the resulting sub-proteins do is still unclear. As Rümenapf says, "People have been actively studying the NS3 for about twenty years so we were amazed to find new cleavage sites. The knowledge that NS3 is auto-cleaved changes the way we think about how the virus works and could be very helpful in understanding the complex regulation of that – in some flaviviruses such as hepatitis C virus and CSFV – leads to persistent infections."

Explore further: Protease inhibitor resistance involves multiple stages of the HIV-1 life cycle

More information: The paper "Autocatalytic Cleavage within Classical Swine Fever Virus NS3 Leads to a Functional Separation of Protease and Helicase" by Benjamin Lamp, Christiane Riedel, Eveline Wentz, Maria-Alejandra Tortorici and Till Rümenapf has just been published in the Journal of Virology (DOI: 10.1128/JVI.00754-13).

Related Stories

Protease inhibitor resistance involves multiple stages of the HIV-1 life cycle

August 27, 2013
HIV-1 protease inhibitors are very effective antiviral drugs. These drugs target HIV-1 proteases, which are required for viral replication. Despite the success of protease inhibitors for suppressing HIV-1, some patients do ...

New findings could influence the development of therapies to treat dengue disease

August 2, 2013
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four ...

Researchers developing drug to combat west nile virus, other related viruses

June 8, 2012
(Medical Xpress) -- Professors at Colorado State University and the University of Northern Colorado are developing a drug that can stop replication of West Nile, dengue and yellow fever viruses that continue to plague two-thirds ...

Foot soldiers of the immune system: IFIT antiviral protein recognizes foreign RNA and blocks viral infections

January 13, 2013
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein. This key protein enables the human ...

Recommended for you

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

New vaccine production could improve flu shot accuracy

July 24, 2017
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.